CoMind
Focus: CoMind develops a non-invasive brain monitoring system focused on neurology applications, currently in early-stage clinical validation. The company is publicly listed but appears to be in pre-commercialization phase with minimal product revenue.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$102.5M
Open Jobs
11-12 this month
Cooling — net -12 jobs in 30d
5 added, 17 removed. Slower than typical.
Should You Work at CoMind?
AI assessmentCoMind is a high-risk, high-impact early-stage play for technologists and neurology specialists willing to bet on novel hardware platforms and IPO-level organizational maturity.
Why Work Here
- Join a publicly-traded medtech innovator developing novel non-invasive brain monitoring technology with significant unmet clinical need in neurology
- Heavy IT hiring (9 of 17 roles) signals platform-software scaling and digital health infrastructure buildout—rare skillset combination in biotech
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CoMind Early Feasibility Study
Intracranial PressureClinical Trials (1)
NCT06368648CoMind Early Feasibility Study
N/AHelp build intelligence for CoMind
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.